From: The impact of lung ultrasound on clinical-decision making across departments: a systematic review
Study | Year | Patients (n), symptom | Ultrasound | Diagnosis change | Management change | Therapy change | Type of therapy changes |
---|---|---|---|---|---|---|---|
House | 2020 | 280, dyspnea | Lung | 124 (44.3%) | 150 (53.6%) | 125 (44.6%) | Invasive 9/125 n-Invasive 116/125 |
Shah | 2016 | 117, dyspnea | Lung + cardiac | 18 (15.4%) | 23 (19.6%) | 23 (19.6%) | Invasive 1/23 n-Invasive 22/23 |
Russell | 2015 | 99, dyspnea | Lung + cardiac + caval | 17 (17%) | 47 (47%) | 42 (42%) | Invasive 2/42 n-Invasive 40/42 |
Goffi | 2013 | 50, dyspnea | Lung | 22 (44%) | 40 (80%) | 35 (70%) | Invasive 6/35 n-Invasive 29/35 |
Total | Â | 546 | Â | 181 (33.2%) | 260 (47.6%) | 225 (41.2%) | Invasive 18/225 n-invasive 207/225 |
Yuan | 2001 | 78 acute chest symptoms | Lung + cardiac | 52 (66.7%) | 35 (44.9%) | 34 (43.6%) | Invasive 17/34 n-Invasive 17/34 |